News
Latest Focus Area News
- Increased cancer risk associated with vitamin and calcium supplements (9 Apr 2019)
- Parathyroid hormone levels do not determine risk of hyperparathyroidism complications (5 Apr 2019)
- Genome studies identify new osteoporosis risk genes (27 Mar 2019)
- Child vitamin D supplements may lack recommended dose (27 Feb 2019)
Latest ESE News
ESE on Demand
Explore content and highlights from ECE 2019 - filtered by your Focus Area
Plus all content for the 2017 and 2018 congressesThe ESE PARAT Programme
Improving future outcomes and care for patients with parathyroid disordersFocus Area Events
-
10 Jan 2020ESE Clinical Update, Abu Dhabi Abu Dhabi, UAE
-
3 Feb 2020ECE 2020 Abstract Submission Deadline
-
19 - 22 Mar 202026th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism Tbilisi, Georgia
-
8 Apr 2020ECE 2020 Early Bird Registration Deadline
-
24 - 25 Apr 2020Postgraduate Training Course in Clinical Endocrinology Zagreb, Croatia
-
23 - 26 May 202022nd European Congress of Endocrinology Prague, Czech Republic
Guidelines
- European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults
- External Guideline: Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- External Guideline: Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group
- External Guideline: Clinical guidelines for management of bone health in Rett syndrome based on expert consensus and available evidence
- External Guideline: Revisiting KDIGO clinical practice guideline on chronic kidney disease—mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference
- External Guideline: Vitamin D supplementation guidelines
- External Guideline: The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism